SCIENCE-JOBS-DE

 The successful candidate will be involved in studies on intracellular signaling pathways involving PI3K isoforms and receptor tyrosine kinases in human cancer. The studies will involve a combination of cell biology and molecular biology, including RNAi screens, next generation sequencing and phosphoproteomics. Selected publications from the laboratory include: Salm et al. Oncogene 2013, in press; Wojtalla et al. Clin. Cancer Res. 2013, 19, 96; Guerreiro et al. Mol. Cancer Res. 2011, 9, 925; De Laurentiis et al. Cell. Signal. 2011, 23, 529; Marinov et al. Clin. Cancer Res. 2009, 15, 1277; Guerreiro et al. Clin. Cancer Res. 2008, 14, 676; Boller et al. Clin. Cancer Res. 2008, 14, 1172; Doepfner et al. Leukemia 2007, 21, 1921; Arcaro et al. Biochem. J. 2007, 406, 57; Arcaro et al. Cell. Signal. 2007, 19, 1081; Guerreiro!

  et al. Int. J. Cancer 2006, 119, 2527; Khanzada et al. Oncogene 2006, 25, 877; Katso et al. Mol. Biol. Cell 2006; 17, 3729.

Requirements: Master degree in Science or Biomedical Sciences or equivalent. Applicants must be eligible for registration as PhD student to the Graduate School of Bern (see also www.gcb.unibe.ch)

Offer: We offer support to successfully obtain a PhD degree of the Graduate School at University of Bern, Switzerland. Salary will be according to SNF guidelines.

Workload: 100%

Entrance upon: May 2013 or upon agreement

Duration: 36 months

Application: By e-mail to PD Dr. Alexandre Arcaro, Department of Clinical Research, University of Bern, Murtenstrasse 31, Postfach 33, CH-3010 Bern, Switzerland (letter of motivation, CV and letter plus phone number of two academic referees in a single PDF file).

Email: alexandre.arcaro@dkf.unibe.ch